Literature DB >> 21334027

6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training.

Rodney U Anderson1, David Wise, Timothy Sawyer, Patricia Glowe, Elaine K Orenberg.   

Abstract

PURPOSE: Chronic prostatitis/chronic pelvic pain syndrome continues to elude conventional therapy. Evidence supports the concept that phenotypes of pelvic muscular tenderness and psychosocial distress respond to myofascial trigger point release and specific relaxation training. This case series reports long-term outcomes of a 6-day intensive combination of such therapies in refractory cases.
MATERIALS AND METHODS: A total of 200 men with pain for a median of 4.8 years referred themselves to Stanford University Urology for participation in an established protocol. Daily 3 to 5-hour sessions including intrapelvic/extrapelvic physiotherapy, self-treatment training and paradoxical relaxation training provided a solid introduction to facilitate self-management. Subjects answered baseline and followup questionnaires at variable intervals after initiation of therapy including the National Institutes of Health Chronic Prostatitis Symptom Index, global response assessment and a psychological query.
RESULTS: We followed 116 men for a median of 6 months. Baseline total symptom index was 26 out of a maximum 43 points. Scores decreased by 30% (p <0.001) at followup with 60% of subjects demonstrating a 6-point or greater decrease (range 6 to 30). Domains of pain, urinary dysfunction and quality of life showed significant improvement (p <0.001). Global response assessment revealed that 82% of subjects reported improvement (59% marked to moderate, 23% slight).
CONCLUSIONS: Men with chronic pelvic pain refractory to traditional treatment benefit from intensive myofascial trigger point therapy and concomitant paradoxical relaxation training. Education in techniques for self-administered trigger point release and continued pelvic muscle relaxation help patients reduce pain and dysfunction. Refinement of clinical phenotyping and selection of patients with pelvic muscle tenderness should enhance the success rate with this treatment modality.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21334027     DOI: 10.1016/j.juro.2010.11.076

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  Myofascial pelvic pain.

Authors:  Rhonda Kotarinos
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Dry needling - peripheral and central considerations.

Authors:  Jan Dommerholt
Journal:  J Man Manip Ther       Date:  2011-11

Review 3.  Pelvic floor therapies in chronic pelvic pain syndrome.

Authors:  Ragi Doggweiler; Adam F Stewart
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

Review 4.  Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system.

Authors:  Daniel A Shoskes; J Curtis Nickel
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

Review 5.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.

Authors:  A S Polackwich; D A Shoskes
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

6.  [Long-term effects of osteopathic treatment of chronic prostatitis with chronic pelvic pain syndrome: a 5-year follow-up of a randomized controlled trial and considerations on the pathophysiological context].

Authors:  S Marx; U Cimniak; M Rütz; K L Resch
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

Review 7.  Recognizing myofascial pelvic pain in the female patient with chronic pelvic pain.

Authors:  Elizabeth A Pastore; Wendy B Katzman
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2012-08-03

8.  A 2-year follow-up of quality of life, pain, and psychosocial factors in patients with chronic prostatitis/chronic pelvic pain syndrome and their spouses.

Authors:  Dean A Tripp; J Curtis Nickel; Daniel Shoskes; Adrijana Koljuskov
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

Review 9.  Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact.

Authors:  J Curtis Nickel; Daniel A Shoskes; Florian M E Wagenlehner
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

Review 10.  The challenge of erectile dysfunction in the man with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.